View in EDS

Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study.

Saved in:
Bibliographic Details
Title: Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study.
Authors: Zhou, Qing1 (AUTHOR), Xu, Chong-Rui1 (AUTHOR), Cheng, Ying2 (AUTHOR), Liu, Yun-Peng3 (AUTHOR), Chen, Gong-Yan4 (AUTHOR), Cui, Jiu-Wei5 (AUTHOR), Yang, Nong6 (AUTHOR), Song, Yong7 (AUTHOR), Li, Xiao-Ling8 (AUTHOR), Lu, Shun9 (AUTHOR), Zhou, Jian-Ying10 (AUTHOR), Ma, Zhi-Yong11 (AUTHOR), Yu, Shi-Ying12 (AUTHOR), Huang, Cheng13 (AUTHOR), Shu, Yong-Qian14 (AUTHOR), Wang, Zhen1 (AUTHOR), Yang, Jin-Ji1 (AUTHOR), Tu, Hai-Yan1 (AUTHOR), Zhong, Wen-Zhao1 (AUTHOR), Wu, Yi-Long1 (AUTHOR) syylwu@live.cn
Source: Cancer Cell. Sep2021, Vol. 39 Issue 9, p1279-1279. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 152273152
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Zhou%2C+Qing%22">Zhou, Qing</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Chong-Rui%22">Xu, Chong-Rui</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cheng%2C+Ying%22">Cheng, Ying</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Yun-Peng%22">Liu, Yun-Peng</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Gong-Yan%22">Chen, Gong-Yan</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cui%2C+Jiu-Wei%22">Cui, Jiu-Wei</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+Nong%22">Yang, Nong</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Song%2C+Yong%22">Song, Yong</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Xiao-Ling%22">Li, Xiao-Ling</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lu%2C+Shun%22">Lu, Shun</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Jian-Ying%22">Zhou, Jian-Ying</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ma%2C+Zhi-Yong%22">Ma, Zhi-Yong</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yu%2C+Shi-Ying%22">Yu, Shi-Ying</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Cheng%22">Huang, Cheng</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shu%2C+Yong-Qian%22">Shu, Yong-Qian</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Zhen%22">Wang, Zhen</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+Jin-Ji%22">Yang, Jin-Ji</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tu%2C+Hai-Yan%22">Tu, Hai-Yan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhong%2C+Wen-Zhao%22">Zhong, Wen-Zhao</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Yi-Long%22">Wu, Yi-Long</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> syylwu@live.cn</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Cancer+Cell%22">Cancer Cell</searchLink>. Sep2021, Vol. 39 Issue 9, p1279-1279. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152273152
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ccell.2021.07.005
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: 1279
    Titles:
      – TitleFull: Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhou, Qing
      – PersonEntity:
          Name:
            NameFull: Xu, Chong-Rui
      – PersonEntity:
          Name:
            NameFull: Cheng, Ying
      – PersonEntity:
          Name:
            NameFull: Liu, Yun-Peng
      – PersonEntity:
          Name:
            NameFull: Chen, Gong-Yan
      – PersonEntity:
          Name:
            NameFull: Cui, Jiu-Wei
      – PersonEntity:
          Name:
            NameFull: Yang, Nong
      – PersonEntity:
          Name:
            NameFull: Song, Yong
      – PersonEntity:
          Name:
            NameFull: Li, Xiao-Ling
      – PersonEntity:
          Name:
            NameFull: Lu, Shun
      – PersonEntity:
          Name:
            NameFull: Zhou, Jian-Ying
      – PersonEntity:
          Name:
            NameFull: Ma, Zhi-Yong
      – PersonEntity:
          Name:
            NameFull: Yu, Shi-Ying
      – PersonEntity:
          Name:
            NameFull: Huang, Cheng
      – PersonEntity:
          Name:
            NameFull: Shu, Yong-Qian
      – PersonEntity:
          Name:
            NameFull: Wang, Zhen
      – PersonEntity:
          Name:
            NameFull: Yang, Jin-Ji
      – PersonEntity:
          Name:
            NameFull: Tu, Hai-Yan
      – PersonEntity:
          Name:
            NameFull: Zhong, Wen-Zhao
      – PersonEntity:
          Name:
            NameFull: Wu, Yi-Long
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 09
              Text: Sep2021
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 15356108
          Numbering:
            – Type: volume
              Value: 39
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Cancer Cell
              Type: main
ResultId 1